WebThalidomide Melphalan Boronic Acids Pyrazines Prednisone Dexamethasone Myeloma Proteins Syndecan-1 Antineoplastic Agents Bence Jones Protein Paraproteins Immunoglobulin Light Chains Proteasome Inhibitors Interleukin-6 Vincristine Immunoglobulin kappa-Chains Diphosphonates Syndecans Antineoplastic Agents, Alkylating Doxorubicin … WebMultiple Myeloma staging: International Staging System (ISS) and the R-ISS ISS stage I Serum b2M < 3.5 mg/L, serum albumin >/=3.5 g/dL II Not ISS stage I or III III Serum b2M …
Second Revision of the International Staging System (R2-ISS
WebPURPOSE: Patients with newly diagnosed multiple myeloma (NDMM) show heterogeneous outcomes, and approximately 60% of them are at intermediate-risk according to the … WebNov 2, 2024 · To evaluate the performance of the second revision of the International Staging System 2 (R2ISS) 1 in a real-world cohort, we applied the scoring system to … scratch bob the builder
Multiple myeloma with high-risk cytogenetics and its treatment …
WebJun 1, 2024 · Furthermore, compared with the R-ISS, the R2-ISS showed an improved discriminating capability, especially in the large group of patients with intermediate-risk … WebMay 9, 2024 · D’Agostino M, Lahuerta J-J, Wester R, Waage A, Bertsch U, Zamagni E, et al. A new risk stratification model (R2-ISS) in newly diagnosed multiple myeloma: analysis … WebNov 5, 2024 · This additive scoring system based on the impact of single risk features could be the future risk stratification model for NDMM, so called "R2-ISS". About half of the pts … scratch bongo cat